US 9303077
Peptide composition for cancer treatment by inhibiting TRPV6 calcium channel activity
granted A61KA61K31/337A61K31/555
Quick answer
US patent 9303077 (Peptide composition for cancer treatment by inhibiting TRPV6 calcium channel activity) held by Soricimed Biopharma Inc. expires Mon Mar 31 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Soricimed Biopharma Inc.
- Grant date
- Tue Apr 05 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 31 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 9
- CPC classes
- A61K, A61K31/337, A61K31/555, A61K38/00, A61K38/1761